World Heart on track for heart assist trial:
This article was originally published in Clinica
World Heart says that it is on track to begin clinical trials of its fully implantable ventricular assist device for treating patients with end-stage heart disease. The HeartSaverVAD is expected to enter clinical trials in Canada in the second half of 2001, says Roderick Bryden, the Ottawa, Ontario company's president and CEO. He added that in vivo preclinical trials and in vitro trials of the device are expected to continue throughout the second and third quarters of the year.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.